EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in Candida auris (Candidozyma auris) Isolates

Deniz Turan iD, Abdurrahman Sarmis iD, Rıza Adaleti iD, Sebahat Aksaray iD

Infection and Drug Resistance · 2026-03 · Volume 19 · 1-11

DOI: 10.2147/idr.s585235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Infection and Drug Resistance, 2026-03. Verfasst von Deniz Turan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul Provincial Health Directorate ISLAB-2 Central Laborator…. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Candida auris poses a global public health threat due to its multidrug resistance and association with severe invasive infections. With limited treatment options, combination therapies are being explored to enhance antifungal efficacy. This study aimed to evaluate the in vitro synergistic activity of anidulafungin combined with isavuconazole, voriconazole, posaconazole, and amphotericin B against clinical C. auris isolates.

Methods

Fifty clinical C. auris isolates were identified via MALDI-TOF MS. Antifungal susceptibility testing was performed using the EUCAST broth microdilution method to determine Minimum Inhibitory Concentrations (MICs). Subsequently, the in vitro interactions of anidulafungin with four other antifungals were assessed using a checkerboard assay. Drug interactions were classified by calculating the Fractional Inhibitory Concentration Index (FICI).

Results

High resistance rates were observed for fluconazole (72%) and amphotericin B (48%), whereas no isolates were resistant to echinocandins. In combination tests, interactions were predominantly indifferent (56– 84%), followed by partial synergy (12– 40%). A single instance of true synergy (FICI = 0.49) was noted with the anidulafungin-posaconazole combination in one isolate. Synergy rates (synergy + partial synergy) varied significantly across combinations (Fisher’s exact test, p = 0.0044), with anidulafungin-azole combinations showing the highest rates (36– 40%) compared to anidulafungin-amphotericin B (12%). No antagonism (FICI ≥ 4) was detected in any combination.

Discussion

The predominance of indifferent interactions, with some partial synergy, suggests that combination therapy may not consistently offer a strong synergistic benefit for these isolates. This exploratory study characterizes the in vitro interaction landscape in our isolate collection, providing foundational data to guide future research and inform clinical decisions where treatment options are scarce. Keywords: candida auris , candidozyma auris , antifungal combination test, anidulafungin, amphotericin B, azole antifungals

Schlagwörter

Stichwörter der Autor:innen

amphotericin Banidulafunginantifungal combination testazole antifungalscandida auriscandidozyma auris

Autor:innen und Institutionen

  • Department of Medical Microbiology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul Provincial Health Directorate ISLAB-2 Central Laboratory, Istanbul, 34722, Turkey.
  • Department of Medical Microbiology, University of Health Sciences Turkey, Haydarpasa Numune Training and Research Hospital, Istanbul, 34668, Turkey.
  • Department of Medical Microbiology, Goztepe Prof. Dr. Suleyman Yalcin City Hospital, Istanbul, 34722, Turkey.
  • Department of Medical Microbiology, University of Health Sciences Turkey, Hamidiye Medical School, Istanbul, 34668, Turkey.

ORCID-Profile: Deniz Turan, Abdurrahman Sarmis, Rıza Adaleti, Sebahat Aksaray

Zitieren

APA

Turan, D., Sarmis, A., Adaleti, R., & Aksaray, S. (2026). Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in Candida auris (Candidozyma auris) Isolates. Infection and Drug Resistance, Volume 19, 1-11. https://doi.org/10.2147/idr.s585235

Vancouver

Turan D, Sarmis A, Adaleti R, Aksaray S. Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in Candida auris (Candidozyma auris) Isolates. Infection and Drug Resistance. 2026;Volume 19:1-11. doi:10.2147/idr.s585235

BibTeX
@article{Turan2026,
  author = {Turan, Deniz and Sarmis, Abdurrahman and Adaleti, Rıza and Aksaray, Sebahat},
  title = {Evaluation of the Synergistic Activity of Anidulafungin with Isavuconazole, Voriconazole, Posaconazole, and Amphotericin B in Candida auris (Candidozyma auris) Isolates},
  journal = {Infection and Drug Resistance},
  year = {2026},
  volume = {Volume 19},
  pages = {1--11},
  doi = {10.2147/idr.s585235}
}
Kostenlos starten →